Rapid and sensitive LC‐MS/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study
- 8 September 2011
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 26 (4) , 491-496
Abstract
A highly sensitive, specific and fully validated LC‐MS/MS method as per general practices of industry has been developed for estimation of lamotrigine (LAM) with 100 μL of human plasma using flucanozole as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode using electrospray ionization. A simple liquid–liquid extraction process was used to extract LAM and IS from human plasma. The total run time was 2.0 min and the elution of LAM and IS occurred at 1.25 and 1.45 min; this was achieved with a mobile phase consisting of 0.1% formic acid–methanol (20:40:40, v/v) at a flow rate of 0.50 mL/min on a Discovery CN (50 × 4.6 mm, 5 µm) column. The developed method was validated in human plasma with a lower limit of quantitation of 0.1 ng/mL for LAM. A linear response function was established for the range of concentrations 0.1–1500 ng/mL (r > 0.998) for LAM. The intra‐ and inter‐day precision values for LAM met the acceptance as per Food and Drug Administration guidelines. LAM was stable in the set of stability studies, viz. bench‐top, autosampler and freeze–thaw cycles. The developed assay method was applied to an oral bioequivalence study in humans. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD)Journal of Chromatography B, 2007
- Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high‐performance liquid chromatographyBiomedical Chromatography, 2007
- Determination of Lamotrigine and its Metabolites in Human Plasma by Liquid Chromatography-Mass SpectrometryTherapeutic Drug Monitoring, 2006
- Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatographyJournal of Chromatography B, 2005
- Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluidJournal of the American Society for Mass Spectrometry, 2003
- The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratoryAnalytica Chimica Acta, 1999
- Simultaneous determination of lamotrigine and its glucuronide and methylated metabolites in human plasma by automated sequential trace enrichment of dialysates and gradient high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Liquid chromatographic determination of plasma lamotrigine in pediatric samplesJournal of Pharmaceutical and Biomedical Analysis, 1996
- LamotrigineDrugs, 1995
- Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humansClinical Pharmacology & Therapeutics, 1987